Plasma P-tau2017 and Quantitative Amyloid PET Imaging
Completed · Phase 1
Conditions studied: Alzheimer Disease
In brief
The overall goal of this protocol is to compare amyloid burden assessed by amyloid PET to plasma P-tau217 levels.
Key facts
- Study ID
- NCT05164536
- Run by
- Invicro
- People needed
- 140
- Starts
- 2021-08-27
- Expected to finish
- 2022-11-08
- Last updated by the study team
- 2025-02-28
Who can join
Age: 70 and older. Sex: any. Healthy volunteers: accepted.
Where it is running
- Invicro — New Haven, Connecticut, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.